A number of laboratories, including our own, are attempting to dissect the neural mechanisms that support and mediate interactions between conscious perception, interoceptive control, and emotional feelings. In parallel, studies of the functional neurobiology of the cognitive control of anxiety and the facilitation of motivational ''unlearning'' and extinction highlight the importance of affective neuroscience to clinical therapeutics. In the study by Naqvi and coworkers, the effects of insula lesions on smoking addiction are reminiscent of an ''interoceptive agnosia'' arising from disruption of viscerosensory representations (Nauta, 1971; Damasio, 1994) . Their study identifies a crucial neural substrate for craving and emphasizes the critical role of conscious feeling states in driving habitual behavior. Underpinning this role of insula cortex in craving is its status as viscerosensory cortex and as the neural substrate for interoceptive feeling states.
Why did not all smokers with insula lesions quit? Obviously a number of factors play a role in the maintenance of addiction, only some of which are usefully explained at the neural level. Of these, alterations in striatal dopaminergic reward-related processing are well recognized to play a critical role. The degree to which reward/goalselection processes and interoceptive awareness of craving differentially contribute to drug-seeking behavior is not known. One important next step in further understanding the interplay between the multiple neural systems mediating addiction (Hyman et al., 2006) would be to dissociate striatal dopaminergic error-prediction signals (Pessiglione et al., 2006) from linear associations between subjective craving and right anterior insula activity within addicted patients.
A critical molecular requirement underlying many forms of long-lasting synaptic plasticity and memory is the de novo synthesis of mRNAs and proteins. In a recent paper in Cell, Costa-Mattioli et al. present data from a pharmacogenetic study that places a key regulatory event in the ''neural decision'' to undergo these persistent neuronal changes under translational control mediated by eIF2a.
An old adage states that ''a moment lasts all of a second, but the memory lives on forever.'' The molecular mechanisms that regulate the ''forever'' or long-term aspects of memory formation have been the subject of intense study for over three decades in more than a dozen model organism systems. Although the temporal boundaries that define long-term memory (LTM) vary significantly between mollusks, insects, and vertebrates, in all cases examined thus far, the synthesis of new mRNAs and proteins gates the transition between short-term memory (STM) and LTM (Klann and Dever, 2004) . These new proteins are believed to produce and maintain longlasting neuronal changes (most likely at the synapse), which are manifested behaviorally as memory. The Holy Grail of memory neuroscience (and to a certain extent, industry nootropic ''smart drug'' efforts) has been the identification of the critical regulator(s), or the ''master,'' molecular switch that controls the transition between shortterm and long-term plastic change.
The first molecule identified that fits the definition of master molecular switch was cAMP element-binding protein (CREB). In simplistic terms, CREB is a transcription factor that promotes the transcription of several downstream gene targets that in turn regulate long-term plasticity. Many studies support the idea that CREB is a critical switch regulating the threshold to enduring neuronal changes. Overexpression of CREB activator isoforms, inhibition of CREB repressor isoforms, or expression of activated CREB constructs enhances synaptic plasticity and LTM in both vertebrate and invertebrate systems (Carlezon et al., 2005) . However, recent studies have identified other potential transcriptional master switches, such as AP1 and c-rel, that have also been implicated in synaptic plasticity and LTM (Levenson et al., 2004; Sanyal et al., 2002) . Regardless, a common theme that emerges is that the master switch in transducing STM to LTM lies squarely within the dominion of transcriptional control. But what about translation, transcription's partner in cellular physiology? Is translation merely an inevitable outcome of mRNA synthesis?
The importance of translation in LTM has been known for at least as long as transcription (Squire and Barondes, 1973) . But strangely enough, the idea that the translational machinery may act as a specific target of regulation during long-lasting plastic processes has only become evident more recently. A key experiment highlighting the critical and separate role of translation in long-term plasticity showed that long-term potentiation (LTP) induced by the neurotrophic factor BDNF remained protein synthesis dependent and persisted at dendrites that had been separated from their cell bodies (Kang and Schuman, 1996) . More recent studies have highlighted the essential role of the translation initiation machinery in plasticity (Banko et al., 2005; Govindarajan et al., 2006; Kelleher et al., 2004; Klann and Dever, 2004) . However, what has yet to be shown is how translation can gate the transition of STM to LTM. CostaMattioli and colleagues (Costa-Mattioli et al., 2007 ) make a compelling case for the identification of just such a translational ''master'' switch.
''With the brain, you know you've got something when you have hold of a molecule in one hand and can feel the tug on behavior with the other.'' This quote (from an unnamed neuroscientist) has been the guiding principle of many genetic disruption studies aimed at examining learning and memory. Genes are knocked out and then effects on plasticity and memory are assessed. Costa-Mattioli et al. examined long-lasting plasticity in heterozygous mutant mice lacking a serine (S51A) phosphorylation site on eIF2a (Costa-Mattioli et al., 2007) . eIF2a is a component of the translation initiation complex that when phosphorylated at S51 acts to repress general translation. Importantly, although eIF2a phosphorylation reduces general translation, the translation of some specific mRNA is enhanced rather than repressed. One mRNA regulated in this fashion is activating transcription factor-4 (ATF4) (Harding et al., 2000) . ATF4 functions as a transcriptional antagonist of CREmediated gene expression, opposing the activity of the activated CREB.
In eIF2a S51A/+ mice, Costa-Mattioli et al. report that ATF4 levels are decreased. Interestingly, they find that the threshold for inducing long-lasting, protein synthesis-dependent latephase LTP (L-LTP) is reduced without altering the manifestation of LTP, suggesting that the function of eIF2a is to regulate the induction of L-LTP rather than the expression or maintenance of L-LTP. Enhanced L-LTP has been demonstrated in other mouse mutants, and rather than improved memory, it is often correlated with learning and memory deficits (Banko et al., 2005; Gu et al., 2002) . What makes the eIF2a S51A/+ mouse intriguing is that the enhanced L-LTP is correlated with enhanced memory in several tasks, including the Morris water maze (MWM), associative conditioned fear, and conditioned taste aversion (CTA). Moreover, it appears that the threshold for the acquisition of longlasting memory in these paradigms has been reduced, as the mice acquire the MWM platform location with fewer trials, exhibit increased freezing to weaker stimuli during fear conditioning, and have faster extinction rates in the latent inhibition version of CTA. In parallel to their LTP findings, the authors found that the overall magnitude of memory in these mice was essentially unchanged. In the MWM, learning rates were increased, and in CTA and conditioned fear, LTM was formed when it would not have been otherwise. These findings strengthen the idea that eIF2a phosphorylation functions to gate longterm neuronal changes rather than alter their expression. Switching strategies, Costa-Mattioli et al. next utilized a pharmacological approach to examine the role of increased eIF2a phosphorylation on long-lasting plasticity. They accomplished this using the drug Sal003, an agent that blocks the activity of eIF2a phosphatases (Boyce et al., 2005) . Using this drug, the authors found that L-LTP was blocked in wild-type slices. In an interesting experiment, they also examine the effects of Sal003 treatment on translation by examining actively translating polysomes. Examining Sal003-treated embryonic fibroblasts, the authors found ATF4 mRNA shifted to actively translating polysome fractions, whereas b-actin mRNA shifted to lower-density fractions. The impact of this experiment would have been more profound if the polysomes were purified from either synaptoneurosomes or cultured hippocampal preparations, but given the quantity of starting material required for this sort of preparation, the authors' compromise is a fair one. Further strengthening their argument, they proceed to demonstrate that not only is dephosphorylation of eIF2a a normal consequence of fear learning, but that Sal003 can impair LTM.
The most convincing and elegant experiment performed by CostaMattioli and colleagues is one utilizing a powerful pharmacogenetic approach. In this experiment, the authors demonstrate that the inhibition of L-LTP by Sal003 is mediated entirely by ATF4. The authors accomplish this by determining that L-LTP in hippocampal slices from ATF4 knockout mice is completely resistant to Sal003 treatment. In other words, the consequences of increased eIF2a phosphorylation, at least with respect to L-LTP, are principally funneled through a single transcription factor, ATF4. In this way, translation rather than transcription acts as the master molecular switch controlling the transition between short-term and long-term plasticity.
The findings of Costa-Mattioli and colleagues highlight a critical relationship between neuronal translation and transcription (Figure 1) . Translation of immediate-early gene products, which in turn feed forward to drive gene expression, has been demonstrated recently (Wagatsuma et al., 2006) . Fragile X mental retardation protein (FMRP) is an RNA-binding protein that acts as a translational repressor by binding numerous G-quartetcontaining mRNAs regulating their accessibility or transport. Levels of FMRP are dynamically regulated by synaptic activity and therefore can viewed as ''upstream'' of transcription by controlling gene expression (Hou et al., 2006) . Other mechanisms influenced by translation that can affect transcription, such as local synthesis of proteosome regulators, which could either degrade transcriptional repressors or induce micro-RNA production, may be other routes through which translation acts to regulate transcription.
Costa-Mattioli et al. demonstrate the critical role of a single phosphorylation site on the translation factor eIF2a in regulating long-lasting synaptic change. Moreover, it moves the crucial ''switch'' event for memory out of the nucleus into the realm of translation by placing phosphorylation of eIF2a upstream of ATF4, a repressor of CREB-mediated transcription. So, is the search for the master switch for memory over? If history is any indicator, then likely not, as memory ''master'' control molecules have been piling up (CaMKII, PKMz, ERK, Fos, C/EBP, and CREB, to name just a few). In addition, important questions remain with respect to eIF2a and its role in long-lasting plasticity and memory: what other mRNAs are upregulated when there is increased eIF2a phosphorylation? How are the kinase and phosphatase activities that modulate eIF2a phosphorylation regulated? Can memory deficits induced by Sal003 also be rescued via deletion of ATF4? The effective development of microarray technology more than a decade ago led numerous labs to engage in screens to identify pools of gene products under the control of specific promoter elements like CRE. The actual number of genes isolated from such work is quite small, which begs the following question: is there really a single (or small number) of molecules that control long-lasting plasticity and/or long-term memory? Studies like the one by Costa-Mattioli et al. argue that this may be the case, but the term ''master'' may be aptly replaced with ''strongly influential.'' Figure 1 . Translational Control Mechanisms that Regulate Gene Expression (A) Transcriptional control via ATF4 resulting from genome-wide inhibition of CRE-dependent gene expression. Expression of ATF4 is regulated by the phosphorylation state of eIF2a. When eIF2a is phosphorylated, general translation is reduced but ATF4 translation is enhanced, which reduces CRE-dependent gene expression. When eIF2a is dephosphorylated, ATF4 inhibition is relieved (described by Costa-Mattioli et al., 2007) . (B) Transcriptional control of gene expression by rapid synthesis of transcription factor (i.e., CREB). Transcription factor availability controls gene expression either via levels or via transport to the nucleus. (C) Regulation of gene expression via mRNA transcript sequestration and transport. RNA-binding proteins (such as FMRP) can bind and prevent mRNA from being translated to protein, thereby blocking gene expression. Proteasome regulatory factors, which could result in either degradation or transport of RNA-binding proteins, could also regulate translation to control gene expression.
